Media & news

From the CEO

by: Richard Laube CEO

Nobel Biocare continues to invest significantly in our R&D efforts and in 2013, we invested a larger amount than that of our closest competitor.

From the CEO

These investments are being made with several simple objectives in mind, each for the benefit of you and your patients.

First of all, our investments enable you to treat patients with a superior treatment outcome, providing functionality, esthetics and longevity.

They also make it possible for you to treat even the most challenging patients. (Consider the ease with which you can deliver a NobelActive 3.0 implant in a very narrow space thanks to treatment planning with NobelClinician.)

Finally, our investments give you the means to treat patients more efficiently—from single-tooth to full-arch restorations—with our immediate loading treatment protocols.

When all is said and done, we believe our innovation efforts—which we pursue in order to help you treat more patients for all indications with fewer surgical interventions, fewer patient visits, higher predictability and less rework—are far more beneficial to you than buying less expensive implants. We invest and innovate to provide you with a competitive advantage. Let us show you what we can do together.